Cleared Traditional

CMV-COMPLEMENT FIXATION ANTIGEN AND NEGATIVE CONTR

K852929 · Microbix Biosystems, Inc. · Microbiology
Nov 1985
Decision
126d
Days
Class 2
Risk

About This 510(k) Submission

K852929 is an FDA 510(k) clearance for the CMV-COMPLEMENT FIXATION ANTIGEN AND NEGATIVE CONTR, a Antiserum, Cf, Cytomegalovirus (Class II — Special Controls, product code GQI), submitted by Microbix Biosystems, Inc. (Canada, CA). The FDA issued a Cleared decision on November 12, 1985, 126 days after receiving the submission on July 9, 1985. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3175.

Submission Details

510(k) Number K852929 FDA.gov
FDA Decision Cleared SESE
Date Received July 09, 1985
Decision Date November 12, 1985
Days to Decision 126 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary —

Device Classification

Product Code GQI — Antiserum, Cf, Cytomegalovirus
Device Class Class II — Special Controls
CFR Regulation 21 CFR 866.3175

Similar Devices — GQI Antiserum, Cf, Cytomegalovirus

All 17
CMV IGG HUMAN SERUM CONTROLS
K951800 · Pyramid Biological Corp. · Nov 1995
ENZYME LINKED IMMUNOABSORBENT ASSAY, CYTOMEGALOVIRUS
K952254 · Pyramid Biological Corp. · Nov 1995
CMV EARLY ANTIGEN TEST
K942171 · Neogenex · Jun 1994
VIRGO (R) CMV-IGG ELISA
K883102 · Electro-Nucleonics, Inc. · Feb 1989
DETECTADOT SYSTEM 2000 CMV IGG TEST
K875159 · Gull Laboratories, Inc. · May 1988
ENZYGNOST ANTI-CMV IGG TEST
K863488 · Behring Diagnostics, Inc. · Jul 1987